Consistent Outcomes With Canagliflozin in Patients With Type 2 Diabetes Across Geographic Regions

Newer researches in the field of Diabetes are bringing up newer molecules, one such introduced in the last decade is called SGLT2 Inhibitors – an Important one in this group is Canagliflozin. Recently conducted multinational Trial with 10,000 subjects showed this is useful across the continents, all adults, all races and both sexes. For the […]

Type 2 Diabetes, new oral tablet, SGLT2 inhibitor

Management of hyperglycaemia is still a challenge in patients with type 2 diabetes mellitus despite an increase in the pharmacological options. Although metformin is the first drug to be started for the treatment of type 2 diabetes mellitus, some patients may not tolerate it and the many patients do not get adequate control with metformin […]

Protocol for Diabetes Management in hospital – 2014

Name ……………………………….. Hospital No………………. Age/ Sex …………………Ht/Wt …………………….. 1. Diabetes 1) Known diabetes (Type 1 / Type 2 / Others) duration ………… 2) Diabetes – New diagnosis ………………. 3) HbA1C …………… 2. Existing treatment of Diabetes mellitus Name Dose               Primary Consultant   Speciality Nurse –   Speciality Consultant […]

Types of Diabetes

Diabetes, Why Bother Typing? What is Diabetes? Diabetes is a chronic metabolic disorder with high levels of glucose in the blood. A gland in the tummy named pancreas secretes a hormone called Insulin, which controls blood glucose. When we eat, glucose is absorbed from the stomach and enters in the blood. The glucose must enter […]

Treatment with Injection medicine not Insulin

Are there any other new medications available for Diabetes? The search for a new medicine for Diabetes is a never ending process. A new medicine is available which belongs to the incretin family. Incretins are a type of gastrointestinal hormone that cause an increase in the amount of insulin released from the beta cells of […]

Diabetes, Dyslipidemia and Heart Protection

What is dyslipidemia? Cholesterol and triglycerides, known as lipids, are fatty substances normally produces by the body. Dyslipidemia means lipid levels in the bloodstream are too high or low. The most common types of dyslipidemia are : High levels of low-denisty lipoprotein (LDL or “bad”) cholesterol Low levels of high-density lipoproptein 9HDL or “good”) cholesterol […]

New Mode of Insulin Delivery

A new way to treat diabetes may be just around the corner. Several biotechnology companies are in hot pursuit of an oral form of insulin. So far, two options exits for patients with diabetes who require insulin – pumps or syringes, with other needle-free options remaining elusive. In 2007, Pfizer, Inc., withdrew Exubera, an inhaled […]

Insulin Lispro Pregnancy

Insulin Lispro and regular Insulin In Pregnancy A Bhattacharyya, S Brown, S Hughes and P.A.Vice. Insulin Lispro (IL), an analogue of regular human insulin with a peak insulin achieved within an hour of injection, significantly improves post prandial hyperglycaemia. This is very important in diabetic pregnancy, whether gestational or pre-gestational. Patient acceptability has also been […]

Adrenal Crisis

Acute Adrenocortical Crisis: Three Different Presentation A Bhattacharyya, J Macdonald, AA LAkhdar. The adrenal cortex normally produces three principal steroid hormones: the glucocorticoid cortisol, the mineralocorticoid adosterone, and a small quantity of sex steroids. In primary adrenocortical insufficiency, there is a deficiency of both cortisol and aldosterone with characteristic clinical and laboratory findings. In contrast, […]

Diabetes Aetiology

Aetiology and Pathology of Type 2 Diabetes Mellitus A Bhattacharyya Diabetes Mellitus (DM) is a group of metabolic disorders characterized by raised blood sugar due to defects in insulin secretion, action or both. The chronic hyperglycaemia of DM is associated with longterm damage, dysfunction and failure of organs, such as the eyes, kidneys, nerves, blood […]